Adieu: Southampton Branch of the Royal Pharmaceutical Society

– Annals of a sentimental foot soldier by Kazeem Olalekan MRPharmS The last meeting of the Southampton Branch of the Royal Pharmaceutical Society was held on the 22nd of April 2010 at the Drug Safety Research Unit (DSRU) located at Blundell Lane in Bursledon, Southampton. The location is symbolic. If as Pharmacists we are not […]

The PDA Annual Conference 2011

by Kazeem Olalekan MRPharmS The Pharmacy Pharmacists’ defence association (PDA) has fixed this year’s conference for the 26th & 27th February 2011. Bookapharmacist.com is recommending all pharmacists who can attend this event to do so – whether they are members of the PDA or not. The conference website (link) suggest that the conference will appeal […]

A listening group–the ASDA example

Bookapharmacist.com welcomes the bold move by the Superintendent of Asda Pharmacy, John Evans to lead the formation of a Listening group for locum pharmacists. He posted a comment on the Locum Voice website on the 31st of December (link), in which he describes his company’s keenness to “learn what we need to do to support […]

Pharmacist and Sexual Health

Just uncovered this video on YouTube highlighting how pharmacists can play a role in public health in the area of sexual health. The pharmacist can do a lot more of course. So just remember to ask your pharmacist about what helps are available locally. Check the NHS Choices website for more information about sexual health: […]

Change, Stress and Support

by Kazeem Olalekan Change management has been described as structured approach to shifting/transitioning individuals, teams, and organizations from a current state to a desired future state (Wikipedia). UK Pharmacy PLC has undergone and is undergoing significant changes in the way it is configured. With change comes uncertainties and the new Royal Pharmaceutical Society need to […]

Drug Safety Alert – Dronedarone

Dronedarone (Multaqâ–¼) is an antiarrhythmic agent indicated in adult, clinically stable patients with history of, or current, non-permanent atrial fibrillation (AF) to prevent recurrence of AF or to lower ventricular rate. Dronedarone is available as a 400 mg film-coated tablet and the recommended dose is 400 mg twice daily. Dronederone was only approved by NICE […]

Class 3 Drug Alert: Novgos 3.6 mg Implant

Action within 5 days Genus Pharmaceuticals Ltd is temporarily ceasing manufacture of the above product and recalling all remaining stock from pharmacy and wholesaler level. This is due to a small number of problems during implantation and the product is being withdrawn until the implantation system can be made more robust. Product: Genus Pharmaceuticals Ltd […]